Board meeting on 3 November 2026 to consider, approve Q2 and half year unaudited results
GlaxoSmithKline Pharmaceuticals has informed BSE and NSE that its Board of Directors will meet on Tuesday, 3rd November 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Tuesday, 3rd November 2026
- Agenda
- consider, approve and take on record the un-audited financial results for the second quarter and half year ended 30th September 2026
Board meeting scheduled
GlaxoSmithKline Pharmaceuticals has informed BSE and the National Stock Exchange that a meeting of its Board of Directors will be held on Tuesday, 3rd November 2026.
The stated agenda, inter-alia, is to consider, approve and take on record the un-audited financial results for the second quarter and half year ended 30th September 2026.
What this update is
- It is an advance intimation that the Board is meeting on a given date, with the quarterly results on the agenda.
- The results themselves are not part of this intimation. The update only sets out when the Board will meet and what it will consider.
What it means for investors
- The second quarter covers the three months from July to September 2026, and the half year covers April to September 2026.
- Once the Board considers, approves and takes the results on record, the numbers for that period would be disclosed separately.
- Until those results are published, this update on its own does not contain any financial figures to assess.
How it may be perceived
- A scheduled board meeting to take quarterly results on record is a routine, calendar-driven announcement.
- It gives shareholders advance notice of the date on which the company's quarterly performance is to be considered by the Board.
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.